A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
New England Journal of Medicine · 04.01.2024 · 390 (1) · 20-31
DOI: 10.1056/nejmoa2305635 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 04.01.2024. Verfasst von Mohit Mathur und 12 weiteren Autor:innen. Beteiligte Einrichtung: From Visterra, Waltham, MA (M.M., J.Y., B.J.G.P.); John Walls Renal Unit, Leicester General Hospital, Leicester, United Kingdom (J.B.); Nephrology an…. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Antibodies, Monoclonal, Humanized, Tumor Necrosis Factor Ligand Superfamily Member 13. Die Arbeit wurde bisher 236-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: DBT-Wellcome Trust India Alliance, Visterra, Inc., a member of the Otsuka family of companies.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Visterra, Waltham, MA (M.M., J.Y., B.J.G.P.); John Walls Renal Unit, Leicester General Hospital, Leicester, United Kingdom (J.B.); Nephrology and Transplantation, John Hunter Hospital and University of Newcastle, N…
Förderung
- DBT-Wellcome Trust India Alliance
- Visterra, Inc., a member of the Otsuka family of companies
Zitieren
APA
Mathur, M., Barratt, J., Chacko, B., Chan, T. M., Kooienga, L., Oh, K. H., Sahay, M., Suzuki, Y., Wong, M. G., Yarbrough, J., Xia, J., Pereira, B. J. G., & ENVISION Trial Investigators Group (2024). A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. New England Journal of Medicine, 390(1), 20-31. https://doi.org/10.1056/nejmoa2305635
Vancouver
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, et al. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. New England Journal of Medicine. 2024;390(1):20-31. doi:10.1056/nejmoa2305635
BibTeX
@article{Mathur2024,
author = {Mathur, Mohit and Barratt, Jonathan and Chacko, Bobby and Chan, Tak Mao and Kooienga, Laura and Oh, Kook-Hwan and Sahay, Manisha and Suzuki, Yusuke and Wong, Muh Geot and Yarbrough, Jill and Xia, Jing and Pereira, Brian J G and ENVISION Trial Investigators Group, ENVISION Trial Investigators Group},
title = {A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {1},
pages = {20--31},
doi = {10.1056/nejmoa2305635}
}
EUVIMED